Opinion|Videos|June 19, 2024
Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates
The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- Could you discuss disease modifying and other therapies for Alzheimer disease that are currently in development?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD
3
How Do GLP-1 Agonists Fit Into Stroke Care?
4
Redefining Stroke Recovery Beyond Physical Function: Alison Holman, PhD, FNP
5
